Cargando…
Sample Size Determination for Individual Bioequivalence Inference
Statistical criterion for evaluation of individual bioequivalence (IBE) between generic and innovative products often involves a function of the second moments of normal distributions. Under replicated crossover designs, the aggregate criterion for IBE proposed by the guidance of the U.S. Food and D...
Autores principales: | Chiang, Chieh, Hsiao, Chin-Fu, Liu, Jen-Pei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195669/ https://www.ncbi.nlm.nih.gov/pubmed/25310592 http://dx.doi.org/10.1371/journal.pone.0109746 |
Ejemplares similares
-
Adaptive two-stage bioequivalence trials with early stopping and sample size re-estimation
por: Koenig, Franz, et al.
Publicado: (2015) -
Sample size determination for a specific region in multiregional clinical trials with multiple co-primary endpoints
por: Huang, Wong-Shian, et al.
Publicado: (2017) -
Determination of Actarit from Human Plasma for Bioequivalence Studies
por: Loya, P., et al.
Publicado: (2010) -
Evaluation of model‐based bioequivalence approach for single sample pharmacokinetic studies
por: Tardivon, Coralie, et al.
Publicado: (2023) -
Stratum Corneum Sampling to Assess Bioequivalence between Topical Acyclovir Products
por: Pensado, A., et al.
Publicado: (2019)